Publicerade rapporter och nyheter

DateTimeSubjectDocuments
2/21/20171:45 PMOncology Venture: Optimized LiPlaCis® allows for easier storage and transportationSee pressrelease - Oncology Venture
2/21/20171:45 PMOncology Venture: Optimerad LiPlaCis® möjliggör enklare förvaring och transportSe pressmeddelandet - Oncology Venture
2/13/20178:45 AMOncology Venture: Invitation to Attend the Extraordinary General Meeting of Shareholders of Oncology Venture Sweden AB (publ)See press release - Oncology Venture
2/13/20178:45 AMOncology Venture: Kallelse till extra bolagsstämma i Oncology Venture Sweden AB (publ)Se pressmeddelande - Oncology Venture
2/13/20178:30 AMOncology Venture: Decision on rights issue subject to approval at Extraordinary General MeetingSee press release - Oncology Venture
2/13/20178:30 AMOncology Venture: Beslut om företrädesemission villkorat av godkännande vid extra bolagsstämmaSe pressmeddelande - Oncology Venture
2/8/20179:10 AMOncology Venture: Bokslutskommuniké 2016-01-01 - 2016-12-31Se hela bokslutskommunikén  - Oncology Venture
1/31/20173:58 PMOncology Venture: Status and Up-date on Oncology Venture & SPV pipelinesSee press release - Oncology Venture
1/31/20173:58 PMOncology Venture: Statusuppdatering avseende Oncology Ventures och SPV:ernas pipelineSe pressmeddelandet - Oncology Venture
1/24/201711:30 AMOncology Venture: DRP successfully predicts effect of 4 Breast Cancer drugs for Personalized MedicineSee press release - Oncology Venture
1/24/201711:30 AMOncology Venture: DRP förutspår framgångsrikt effekten av 4 bröstcancerläkemedel för Personalized MedicineSe pressmeddelandet - Oncology Venture
1/19/20172:30 PMOncology Venture: EUROSTARS-finansiering om cirka 1,9 MEUR (18 MSEK) har beviljats för OV:s LiPlaCis i fas 2Se pressmeddeladet  - Oncology Venture
1/19/20172:30 PMOncology Venture: EUROSTARS funding of app. 1.9 mEUR (18 mSEK) granted to OV's LiPlaCis Phase 2 projectSee press release - Oncology Venture
1/17/201711:43 AMOncology Venture: Communiqué from the Extraordinary Shareholders' Meeting of Oncology Venture Sweden AB (publ)See press release - Oncology Venture
1/17/201711:43 AMOncology Venture: Kommuniké från extra bolagsstämma i Oncology Venture Sweden AB (publ)Se pressmeddelande - Oncology Venture
1  2  3  4  5  6  7  8  

  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se